Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT01394120
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of pancreas adenocarcinoma
* Clinical stage IV
* Feasible patient for chemotherapy
* Availability of tumor tissue or possibility of a tumor biopsy to define therapeutic targets
* Informed written consent
Exclusion Criteria:
* Previous systemic treatment for advanced pancreas adenocarcinoma
* Contraindication to the administration of any of the drugs used in the study: capecitabine, 5Fluouracil, irinotecan, oxaliplatin, gemcitabine or erlotinib
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01394120
Study Brief:
Protocol Section:
NCT01394120